Clinical Trials Directory

Trials / Completed

CompletedNCT05508269

Genetics of Ischemic Cardiomyopathy

Quantitative Polymerase Chain Reaction of Four Genes in Coronary Artery Disease, Myocardial Infarction and Ischemic Cardiomyopathy

Status
Completed
Phase
Study type
Observational
Enrollment
26 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Background:Ischemic heart disease is one of the heaviest health-related burdens worldwide.We aimed to identify the common hub mRNA and pathways that are involved in pathological progression of ischemic cardiomyopathy. Methods: To explore potential differentially expressed genes (DEGs) of all ischemic heart disease stages, we used chipster and GEO2R tools to analyze of retrieved eight high throughput RNA datasets obtained from GEO database. Gene Ontology functional annotation and Pathways enrichment analyses were used to obtain the common functional enriched DEGs which were visualized in protein-protein interactions (PPI) network to explore the hub mRNA according to the interaction scores. Validation qRT-PCR was carried out for blood and cardiac biopsies compared with controls to validate the determined four hub mRNAs and subsequently reviewed inside comprehensive published meta-analysis database. The validated mRNAs were visualized in two interaction modules. Finally screening of approved drugs was applied.

Conditions

Interventions

TypeNameDescription
GENETICquantitative polymerase chain reaction(QPCR) for four genesquantitative polymerase chain reaction(QPCR) for four genes
PROCEDURECardiac biopsy, blood samplingIn the studied thirteen peripheral blood subjects, five milliliters blood samples were taken from each patient in potassium EDTA tubes, immediately inserted in liquid nitrogen container and then stored in -80 refrigerators. All studied thirteen cardiac tissue subjects were underwent cardiac biopsy after PCI in order to take two specimens from the left ventricle using judkin right seven french catheters for femoral access and cardiac bioptome 2.3 mm wide. All cardiac specimens were collected in cryotubes, immediately inserted in liquid nitrogen container and then stored in -80 refrigerators.

Timeline

Start date
2021-04-01
Primary completion
2022-08-17
Completion
2022-08-17
First posted
2022-08-19
Last updated
2023-01-26

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05508269. Inclusion in this directory is not an endorsement.